Diranersen Slows Early Alzheimer's by Targeting Tau

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.

An experimental drug may help people with early Alzheimer's disease. This drug lowers a brain protein called tau.

The new drug also showed signs of slowing down memory loss. This effect was similar to other existing Alzheimer's medicines.

This drug works by telling the body to make less tau protein. Doctors give the drug as a shot into the spinal fluid.

The study found that the lowest dose worked best to slow decline. People had some confusion, but there was no serious brain swelling.

More studies on tau protein and Alzheimer's disease are starting soon. Scientists are also testing new vaccines and other drug ideas.

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

What does the experimental drug do for people with early Alzheimer's disease?

The drug lowers a brain protein called tau.

How is the drug given to patients?

Doctors give the drug as a shot into the spinal fluid.

What did the study find about the lowest dose of the drug?

The lowest dose worked best to slow decline.

Look at the article image and describe what you see on it. You may either speak or write your answer there.

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com